[HIV infections in the Frankfurt area: results of viral serologic laboratory diagnosis] NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[HIV infections in the Frankfurt area: results of viral serologic laboratory diagnosis]

Immun Infekt. 1987 Nov;15(6):220-3. Unique Identifier : AIDSLINE MED/88138349
Doerr HW; Heinemann D; Klenk T; Schildwachter K; Abteilung fur Medizinische Virologie, Universitatsklinikums; Frankfurt.

Abstract: Basing on routine laboratory diagnosis of serum antibodies to the human immunodeficiency virus (HIV-1) in the years 1985 and 1986, the monthly detection rate of infection amounts to 50 persons on an average in the region of Frankfurt/FRG. The relation of female to male persons changed from 1:7 to 1:3 during one year. This might be influenced by a screening programme performed with female prostitutes who are found seropositive in about 2.5%. In December 1986, the first case of an HIV-2 infection was recorded. The clinical examination of HIV-infected patients admitted to the City Hospital of Offenbach/FRG revealed striking signs in about 35-40%, of AIDS in 6%. The infected persons belong to risk groups. No positive result was seen in pregnant women (n = 1100), medical staff (n = 405) and patients requiring renal transplants (n = 115) who do not belong to the risk groups.
Keywords: Acquired Immunodeficiency Syndrome/*DIAGNOSIS/IMMUNOLOGY Adolescence Adult Cross-Sectional Studies English Abstract Female Germany, West Human HIV/*IMMUNOLOGY Male Middle Age Pregnancy Risk Factors JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDdiagnosis/immunologyadolescenceadultcross-sectionalstudiesenglishabstractfemalegermany,westhumanhiv/KWDimmunologymalemiddleagepregnancyriskfactorsjournalarticle
880630
M8860432

Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .